www.fasenrahcp.com – MashupMD

Mashup Score: 0

FASENRA® (benralizumab) for Severe Eosinophilic Asthma | For HCPs - 29 day(s) ago

FASENRA is indicated for the add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype.

Source: www.fasenrahcp.com

Categories: General Medicine News, Allergy-Immunology

Tweet Tweets with this article
- ACAAI
  
  Sponsored Content: Visit AstraZeneca’s Product Theater (non-CME), Saturday, Oct. 26, 11:35 AM, Exhibit Hall, Theater 1. https://t.co/eElTMsCBCY https://t.co/M9gSQUoUmP

Mashup Score: 0

FASENRA® (benralizumab) for Severe Eosinophilic Asthma | For HCPs - 2 year(s) ago

FASENRA® (benralizumab) is indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Source: www.fasenrahcp.com

Categories: Allergy-Immunology, Latest Headlines

Tweet Tweets with this article
- ACAAI
  
  Sponsored Content: Visit our Product Theater (non-CME), Saturday, Nov 12, 9:35 am, Theater 1. https://t.co/Tr2PUwb3Ap https://t.co/2yQdXkKfef